NCT06948357View on ClinicalTrials.gov

Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions
Presbyopia
Interventions
DRUG

BRIMOCHOL PF eye drops; CARBACHOL PF eye drops; Brimonidine eye drops; Placebo

BRIMOCHOL PF eye drops, CARBACHOL PF eye drops, Brimonidine eye drops and Placebo were administered in 7 treatment sequences in various combinations and doses

Trial Locations (1)

Unknown

RECRUITING

Optometry Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY